OPKO Health, Inc. (OPK)
- Previous Close
1.4700 - Open
1.4600 - Bid 1.4500 x 1800
- Ask 1.4800 x 2500
- Day's Range
1.4200 - 1.5000 - 52 Week Range
0.8500 - 1.7500 - Volume
3,098,839 - Avg. Volume
3,380,789 - Market Cap (intraday)
1.01B - Beta (5Y Monthly) 1.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3300 - Earnings Date Nov 4, 2024 - Nov 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.96
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.
www.opko.com3,930
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OPK
View MorePerformance Overview: OPK
Trailing total returns as of 10/11/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OPK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OPK
View MoreValuation Measures
Market Cap
1.01B
Enterprise Value
1.24B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.48
Price/Book (mrq)
0.72
Enterprise Value/Revenue
1.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-33.93%
Return on Assets (ttm)
-8.09%
Return on Equity (ttm)
-16.59%
Revenue (ttm)
716.37M
Net Income Avi to Common (ttm)
-243.1M
Diluted EPS (ttm)
-0.3300
Balance Sheet and Cash Flow
Total Cash (mrq)
40.58M
Total Debt/Equity (mrq)
19.31%
Levered Free Cash Flow (ttm)
-76.7M
Research Analysis: OPK
View MoreCompany Insights: OPK
OPK does not have Company Insights
Research Reports: OPK
View MoreDaily – Vickers Top Insider Picks for 03/15/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 03/14/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 03/13/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 03/12/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.